Evidence map›Paper›PMID 25350457›Full record

ArticlePloS one2014

Functional characterization of sticholysin I and W111C mutant reveals the sequence of the actinoporin's pore assembly.

Valeria Antonini, Victor Pérez-Barzaga, Silvia Bampi, David Pentón, Diana Martínez, Mauro Dalla Serra, Mayra Tejuca

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
8.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Bacterial pore-forming toxins.Microbiology (Reading, England) · 2022
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Valeria AntoniniNational Research Council of Italy - Institute of Biophysics and Bruno Kessler Foundation, Trento, Italy.
Victor Pérez-BarzagaCenter for Protein Studies, Faculty of Biology, University of Havana, Vedado, Ciudad de La Habana, Cuba.
Silvia BampiNational Research Council of Italy - Institute of Biophysics and Bruno Kessler Foundation, Trento, Italy.
David PentónCenter for Protein Studies, Faculty of Biology, University of Havana, Vedado, Ciudad de La Habana, Cuba.
Diana MartínezCenter for Protein Studies, Faculty of Biology, University of Havana, Vedado, Ciudad de La Habana, Cuba.
Mauro Dalla SerraNational Research Council of Italy - Institute of Biophysics and Bruno Kessler Foundation, Trento, Italy.
Mayra TejucaCenter for Protein Studies, Faculty of Biology, University of Havana, Vedado, Ciudad de La Habana, Cuba.
University of Havana · CUKessler Foundation · USNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of pore-forming toxins in the construction of immunotoxins against tumour cells is an alternative for cancer therapy. In this protein family one of the most potent toxins are the actinoporins, cytolysins from sea anemones. We work on the construction of tumour proteinase-activated immunotoxins using sticholysin I (StI), an actinoporin isolated from the sea anemone Stichodactyla helianthus. To accomplish this objective, recombinant StI (StIr) with a mutation in the membrane binding region has been employed. In this work, it was evaluated the impact of mutating tryptophan 111 to cysteine on the toxin pore forming capability. StI W111C is still able to permeabilize erythrocytes and liposomes, but at ten-fold higher concentration than StI. This is due to its lower affinity for the membrane, which corroborates the importance of residue 111 for the binding of actinoporins to the lipid bilayer. In agreement, other functional characteristics not directly associated to the binding, are essentially the same for both variants, that is, pores have oligomeric structures with similar radii, conductance, cation-selectivity, and instantaneous current-voltage behavior. In addition, this work provides experimental evidence sustaining the toroidal protein-lipid actinoporins lytic structures, since the toxins provoke the trans-bilayer movement (flip-flop) of a pyrene-labeled analogue of phosphatidylcholine in liposomes, indicating the existence of continuity between the outer and the inner membrane leaflet. Finally, our planar lipid membranes results have also contributed to a better understanding of the actinoporin's pore assembly mechanism. After the toxin binding and the N-terminal insertion in the lipid membrane, the pore assembly occurs by passing through different transient sub-conductance states. These states, usually 3 or 4, are due to the successive incorporation of N-terminal α-helices and lipid heads to the growing pores until a stable toroidal oligomeric structure is formed, which is mainly tetrameric.

Indexed as

AdsorptionAnimalsCryoelectron MicroscopyCysteineElectric ConductivityErythrocytesHemolysisHumansImmunotoxinsIonsLipid BilayersLipidsLiposomesMutationOrganic ChemicalsPermeabilityCysteineImmunotoxinsIonsLipid BilayersLipidsLiposomesOrganic ChemicalsPhosphatidylcholinesRecombinant Proteinsstycholysin I

Identifiers

PMID25350457
PMCPMC4211696
OpenAlexW1979048239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.